Related Experiment Video
Updated: Feb 5, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Identifying and assessing potential harm of medication errors and potentially unsafe medication practices in
Rikke Mie Rishoej1, Anna Birna Almarsdóttir2, Henrik Thybo Christesen3
1Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, JB Winsløws Vej 19, 2, Odense C, Funen 5000, Denmark.
Insights
Medication errors and unsafe practices were observed in hospitalized children, but no actual harm occurred. Rater agreement on potential harm was low, indicating a need for better error assessment methods.
Area of Science:
- Pediatric patient safety
- Medication safety research
- Healthcare quality improvement
Background:
- Hospitalized children face risks from medication errors (MEs).
- Identifying process failures is key to preventing MEs.
- This study focused on MEs and potentially unsafe medication practices (PUMPs) in pediatric inpatients.
Purpose of the Study:
- To identify MEs and PUMPs in hospitalized children.
- To assess the potential harm of identified errors and practices.
- To evaluate inter-rater agreement on harm assessment.
Main Methods:
- One-week observational study on four pediatric wards.
- Documentation of MEs and PUMPs during prescribing, preparation, and administration.
- Harm assessment by a physician, nurse, and clinical pharmacist using a Likert scale.
Main Results:
- 16 MEs and 809 PUMPs identified; 8% error rate in preparation/administration.
- No actual patient harm observed.
- Low inter-rater agreement (Kappa = 0.26-0.33) on potential harm; highest score for delayed cefuroxime administration.
Conclusions:
- MEs and unsafe practices pose risks to hospitalized children's medication safety.
- Observed MEs did not lead to patient harm.
- Low rater agreement necessitates alternative methods for determining clinical relevance of errors.
Background:
Hospitalized children are prone to experience harm from medication errors (MEs). Strategies to prevent MEs can be developed from identified malfunctioning practices and conditions in the medication use process. In this study, we aimed to identify MEs and potentially unsafe medication practices (PUMPs) in hospitalized children, and to assess the potential harm of these, using raters of different professions.
Methods:
A 1-week observation using an undisguised technique was conducted on four paediatric hospital wards. One observer followed ward staff during medication prescribing, preparation and administration. MEs and PUMPs were documented using field notes. Three raters including a physician, a nurse and a clinical pharmacist assessed the potential harm of each ME and PUMP using a six-point Likert scale. Agreement was analysed using Fleiss' Kappa.
Results:
A total of 16 MEs and 809 PUMPs were identified involving a preparation and administration error rate of 8%. No actual harm to patients was observed during the study. Raters assessed the potential harm of 318 unique MEs and PUMPs. Only slight agreement was found (Kappa = 0.26-0.33). A 4-hour delay in the administration of intravenous cefuroxime received the highest harm score. Observations involving no information during prescribing and variations in medication preparation were considered potentially fatal for medications such as digoxin, morphine, enoxaparin and insulin.
Conclusions:
MEs and potentially unsafe practices and conditions may affect medication safety of hospitalized children. However, observed MEs did not result in any harm. The agreement among raters assessing the potential harm of observations was low. Alternative methods to determine the clinical relevance of errors are needed.
More Related Videos
09:52Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide
Published on: January 15, 2017
11:29Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study
Published on: August 15, 2025
Related Concept Videos
Nephrotic Syndrome II : Assessment and Medical Management
Inhaled Medications
Endocarditis III: Medical Management
Myocarditis III: Medical Management
Pericarditis III: Medical Management
Heart Failure V: Medical Management